Unresectable Locally Advanced or Metastatic Cancer
Oncology·MeSH: Neoplasm Metastasis
3 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
Phase 1(1)
| Drug | Company |
|---|---|
| AU-007 | ENANTA PHARMACEUTICALS INC (ENTA) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| tak-280 | TAKEDA PHARMACEUTICAL CO LTD (TKPHF) |
Compare drugs
Frequently asked questions
How many drugs are in development for Unresectable Locally Advanced or Metastatic Cancer?
BioSniper tracks 3 drugs in development for Unresectable Locally Advanced or Metastatic Cancer across 3 companies.
How many clinical trials target Unresectable Locally Advanced or Metastatic Cancer?
There are 1 clinical trial targeting Unresectable Locally Advanced or Metastatic Cancer tracked by BioSniper.
Deep-dive into Unresectable Locally Advanced or Metastatic Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis